DSpace JSPUI

BIOREMEDIATION OF LEAD USING LEAD(II) REDUCTASE FOUND IN BACTERIA: IN SILICO MOLECULAR DOCKING See

IN SILICO APPROACH, TO STUDY THE PHYTOCHEMICALS FROM NERIUM OLEANDER AS POTENTIAL MEDICAMENT FOR CARDIAC ARRHYTMIA See

IN SILICO APPROACH FOR THE TREATMENT OF DIABETES TYPE 2 BY TARGETING PTP 1 B WITH PLANT DERIVED NATURAL COMPOUNDS See

DECIPHERING THE THERAPEUTIC POTENTIAL OF MYRICA ESCULENTA IN ASTHAMA TREATMENT : AN IN DEPTH SYSTEMIC PHARMACOLOGY INVESTIGATION INTEGRATING MOLECULAR DOCKING, SIMULATION, UNSUPERVISED MACHINE LEARNING, AND GENE EXPRESSION ANALYSIS See

NETWORK PHARMACOLOGY APPROACH : BIOACTIVE PHYTOCHEMICALS FROM SALVIA OFFICINALIS L.TARGETING SRC FOR THE TREATMENT OF COLORECTAL CANCER See

NANOPARTICLE CATALYSIS: EXPLORING THE EFFECIENCY OF ZINC OXIDE AND CALCIUM OXIDE NANOPARTICLES IN BIODIESEL SYNTHESI See

SULFORAPHANE AND AUTISM SPECTRUM DISORDER: A BIOINFORMATICS APPROACH TO THERAPEUTIC DISCOVERY See

EXPLORING ANTI-ALLERGIC PROPERTIES OF JUSTICIA ADHATODA PLANT FOR TREATMENT OF ALLERGIC RHINITIS USING NETWORK PHARMACOLG AND MOLECULAR DOCKING See

MICROBIAL AND NANOFERTILIZER FOR MITIGATING STRESS IN MEDICINAL PLANTS See

EXAMINING ML ALGORITHMS FOR PARKINSON'S DETECTION THROUGH SPEECH DATASETS : A COMPARATIVE ANALYSIS See

EXPLORING THE POTANTIAL OF Ziziphus jujuba IN ARTERIOSCLEROSIS: A NETWORK PHARMACOLOGY APPROACH See

EXPLORING THE POTENTIAL OF Morindia citrifolia IN TUBERCULOSIS: A NETWORK PHARMACOLOGICAL APPROACH See

TARGETING YIN-YANG 1 INFLAMMATORY PATHWAY AS AN ALTERNATIVE TO MITIGATE THE SYMPTOMS OF MDD See

INNOVATIVE THERAPEUTICS FOR NEURODEGENERATIVE DISEASES : COMPUTATIONAL IDENTIFICATION OF ASK1 INHIBITORS FROM DIVERSE COMPOUND LIBRARIES See

IN-VITRO AND IN-SILICO STUDIES FOR VARIOUS BIOTECHNOLOGICAL ASPECTS OF VITEX NEGUNDO See

IN SILICO STUDY TO DETERMINE THE POTENTIAL OF ALLIUM SATIVM TO PREVENT ISCHEMIC STROKES See

IN SILICO ANALYSIS OF CARNOSIC ACID'S THERAPEUTIC POTENTIAL AS A MULTITARGET INHIBITOR AGAINST NIPAH VIRUS REPLICATION See

ROLE OF SORL1GENE AND ITS PHARMACOLOGICAL INTERACTIONS IN ALZHEIMER'S DISEASE See

REPURPOSING OF DRUGS FOR GLUTAMATE RECEPTOR IN HUNTINGTON’S DISEASE: A BIOINFORMATICS EXPEDITION See